The Anne Lewis Humanitarian Award
The Anne Lewis Humanitarian Award carries the name of the region's ultimate champion on behalf of ALS patients and their families. Anne sets the highest humanitarian standard through her unwavering commitment to improve access to care and expand services for people living with ALS. Her contributions – steadfast work and generous philanthropy – impact the ALS community daily throughout the state. The Anne Lewis Humanitarian Award is bestowed upon leaders in the fight against ALS who exemplify Anne's commitment to the cause and by the virtue of their exemplary work, have a lasting impact on the ALS community.
A Cocktail Reception Celebrating
The Anne Lewis Humanitarian Award
Presented To
Knopp Biosciences
Accepted by Michael Bozik, MD:
President and Chief Executive Officer
Thursday, June 9, 2011
5:30-8:00 p.m.
Fairmont Hotel, Grand Ballroom
The presentation will take place at 6:45 p.m.
About Knopp Biosciences
Knopp Biosciences is being honored with the Anne Lewis Humanitarian Award for its ground-breaking development of a drug that has the potential to halt the progression of ALS. The ALS Association of Western PA believes that the work of Knopp Biosciences represents the most promising news the ALS community has had in decades. Further, their innovation and leadership is providing much-needed hope to a patient group that so desperately deserves it.
Knopp Biosciences is a drug discovery and development company focused on delivering breakthrough treatments for unmet needs. After its founding as an ALS biomarkers company, Knopp initiated development of a potential ALS treatment known as KNS-760704 (dexpramipexole) through preclinical testing, early manufacturing, regulatory interactions, and Phase 1 and Phase 2 clinical trials. With promising initial results, the drug has entered a global Phase 3 study in partnership with Biogen Idec. In parallel, Knopp is expanding laboratory operations to pursue scientific insights gained from the dexpramipexole program. Knopp aims to serve as an anchor for Pittsburgh's emerging biopharmaceutical industry while continuing the search for innovative medicines.
The Anne Lewis Humanitarian Fund
To honor the spirit of Anne's leadership, the Anne Lewis Humanitarian Fund was created to support critical services and programs for ALS patients, their families and caregivers. An ALS patient requires an estimated $250,000 in supplies and care each year. Contributions to the ALHF underwrite services like these:
| Wheelchair Accessible Transportation |
$100/round-trip |
| 4 Hours of Skilled In-Home Care |
$200 |
| Manual Wheelchair |
$600 - 1,200 |
| CoughAssist to Support Breathing |
$3,500 |
| Wheelchair Ramp & Home Installation |
$4,000 - 6,000 |
| Speech Generating Computer |
$9,000 - 12,000 |
| Electric Power Wheelchair |
$30,000 - 60,000 |
Last year, $140,000 was contributed to establish this critical fund. Each year, we work to replenish the fund to support needy patients. Contributions to the fund can be made by credit card at the following link:
Click here to make a donation to THE ANNE LEWIS HUMANITARIAN FUND
Or by sending check or money order to:
The Anne Lewis Humanitarian Fund
c/o ALS Association of Western PA
416 Lincoln Avenue, Pittsburgh, PA 15209
